Patents by Inventor Rajesh H. Bahekar

Rajesh H. Bahekar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptidomimetics with glucagon antagonistic and GLP 1 agonistic activities
    Patent number: 8883963
    Abstract: The present invention provides novel peptidomimetics, of formula (I), which primarily act as glucose dependent insulin secretagogues. Furthermore, it was found that these peptidomimetics showed glucagon receptor antagonistic activity, along with the GLP-I receptor agonistic activity.
    Type: Grant
    Filed: December 10, 2008
    Date of Patent: November 11, 2014
    Assignee: Cadila Healthcare Limited
    Inventors: Rajesh H. Bahekar, Mukul R. Jain, Pankaj Ramanbhai Patel
  • Antidiabetic compounds
    Patent number: 8841413
    Abstract: The present invention provides novel peptidomimetics, of formula (I), which primarily act as glucose dependent insulin secretagogues. Furthermore, it was found that these peptidomimetics showed glucagon receptor antagonistic activity, along with the GLP-1 receptor agonistic activity.
    Type: Grant
    Filed: September 28, 2007
    Date of Patent: September 23, 2014
    Assignee: Cadila Healthcare Limited
    Inventors: Rajesh H. Bahekar, Braj Bhushan Lohray, Vidya Bhushan Lohray, Mukul R. Jain, Kaushik M. Banerjee, Pankaj Ramanbhai Patel
  • Antidiabetic Comppounds
    Publication number: 20130225488
    Abstract: The present invention provides novel peptidomimetics, of formula (I), which primarily act as glucose dependent insulin secretagogues. Furthermore, it was found that these peptidomimetics showed glucagon receptor antagonistic activity, along with the GLP-1 receptor agonistic activity.
    Type: Application
    Filed: September 28, 2007
    Publication date: August 29, 2013
    Inventors: Rajesh H. Bahekar, Braj Bhushan Lohray, Vidya Bhushan Lohray, Mukul R. Jain, Kaushik M. Banerjee, Pankaj Ramanbhai Patel
  • PEPTIDOMIMETICS WITH GLUCAGON ANTAGONISTIC AND GLP 1 AGONISTIC ACTIVITIES
    Publication number: 20120021972
    Abstract: The present invention provides novel peptidomimetics, of formula (I), which primarily act as glucose dependent insulin secretagogues. Furthermore, it was found that these peptidomimetics showed glucagon receptor antagonistic activity, along with the GLP-I receptor agonistic activity.
    Type: Application
    Filed: December 10, 2008
    Publication date: January 26, 2012
    Inventors: Rajesh H. Bahekar, Mukul R. Jain, Pankaj Ramanbhai Patel